Skip to main content
OpenTrials

Clinical trial condition

Stage IA Breast Cancer

Explore clinical trials studying Stage IA Breast Cancer. Study availability and eligibility vary by location and protocol.

51 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IA Breast Cancer trial results

Completed

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

NCT01750073

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +20 more
Locations
  • Nebraska Medicine-Bellevue Bellevue, Nebraska, United States
  • CHI Health Saint Francis Grand Island, Nebraska, United States
  • Nebraska Medicine-Village Pointe Cancer Center Omaha, Nebraska, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

NCT01805076

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Enloe Medical Center Chico, California, United States
View all 179 locations
View Trial Details
Completed

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

NCT00066690

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 500 locations
View Trial Details
Completed

Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

NCT02760030

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor and/or Progesterone Receptor Positive, +12 more
Locations
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Case Western University Cleveland, Ohio, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer

NCT02400060

Conditions
Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Southeastern Medical Oncology Center-Goldsboro Goldsboro, North Carolina, United States
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Fletcher Allen Health Care-Medical Center Burlington, Vermont, United States
View Trial Details

Related conditions